We are live on
!
Find out more
EAM
EULAV Asset Management Portfolio holdings
AUM
$3.13B
1-Year Est. Return
23.04%
This Fund
S&P 500
This Quarter
Est. Return
+9.12%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$3.78B
AUM Growth
+$50.9M
(+1.4%)
Cap. Flow
-$233M
Cap. Flow
% of AUM
-6.16%
Top 10 Holdings %
Top 10 Hldgs %
18.94%
Holding
239
New
2
Increased
37
Reduced
60
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$11.2M |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$5.67M |
| 3 |
Peloton Interactive
PTON
|
+$5.32M |
| 4 |
Exponent
EXPO
|
+$4.61M |
| 5 |
DraftKings
DKNG
|
+$4.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANSS
Ansys
ANSS
|
+$22.8M |
| 2 |
EPAM Systems
EPAM
|
+$14.6M |
| 3 |
HEICO Corp
HEI
|
+$14.4M |
| 4 |
Jack Henry & Associates
JKHY
|
+$14.1M |
| 5 |
Mettler-Toledo International
MTD
|
+$13.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.1% |
| 2 | Healthcare | 16.38% |
| 3 | Industrials | 15.64% |
| 4 | Financials | 12.2% |
| 5 | Consumer Discretionary | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Edwards Lifesciences
EW
$53.9B
| – | – |
-123,000
| Closed | -$10.3M |
|
227
FMC
FMC
$1.3B
| – | – |
-16,600
| Closed | -$1.84M |
|
228
Globe Life
GL
$14.1B
| – | – |
-28,900
| Closed | -$2.79M |
|
229
Keysight
KEYS
$58.8B
| – | – |
-30,200
| Closed | -$4.33M |
|
230
lululemon athletica
LULU
$14.2B
| – | – |
-20,000
| Closed | -$6.13M |
|
231
McCormick & Company Non-Voting
MKC
$14.2B
| – | – |
-36,416
| Closed | -$3.25M |
|
232
Nike
NKE
$61.3B
| – | – |
-32,055
| Closed | -$4.26M |
|
233
Zoetis
ZTS
$31.1B
| – | – |
-23,009
| Closed | -$3.62M |
|
|
KAMN
234
DELISTED
Kaman Corp
KAMN
| – | – |
-29,600
| Closed | -$1.52M |
|
|
COUP
235
DELISTED
Coupa Software Incorporated
COUP
| – | – |
-29,503
| Closed | -$7.51M |
|
|
PLAN
236
DELISTED
Anaplan, Inc.
PLAN
| – | – |
-139,649
| Closed | -$7.52M |
|
|
MIME
237
DELISTED
Mimecast Limited
MIME
| – | – |
-25,700
| Closed | -$1.03M |
|
|
CMD
238
DELISTED
Cantel Medical Corporation
CMD
| – | – |
-16,500
| Closed | -$1.32M |
|
|
IPHI
239
DELISTED
INPHI CORPORATION
IPHI
| – | – |
-47,217
| Closed | -$8.42M |
|
Similar funds
LFG
BI
DIG
BP
CCI
PC
TCG
FTUS
EULAV Asset Management's Q2 2021 Portfolio in Review
As of Q2 2021, EULAV Asset Management held 239 positions worth $3.78B, up 1.4% from $3.73B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
EULAV Asset Management withdrew a net $233M in Q2 2021, closing 17 positions and reducing 60 holdings. Its most notable exit was Automatic Data Processing, an estimated $11.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 34% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, EULAV Asset Management opened a new position in Biogen worth $12.8M.
- EULAV Asset Management's largest Q2 2021 buy was Biogen: 37,000 shares worth $12.8M.
- EULAV Asset Management added most to Splunk Inc in Q2 2021, an estimated $5.67M increase.
- EULAV Asset Management's biggest Q2 2021 reduction was Ansys, cutting an estimated $22.8M.
- EULAV Asset Management fully exited Automatic Data Processing in Q2 2021, selling an estimated $11.3M.
- EULAV Asset Management's ten largest holdings make up 19% of its $3.78B portfolio in Q2 2021.
- EULAV Asset Management opened 2 new positions and closed 17 in Q2 2021.
- EULAV Asset Management's portfolio value rose 1.4% quarter-over-quarter to $3.78B.
Based on EULAV Asset Management's 13F filing for Q2 2021, filed 6 Aug 2021.